Department of Dermatology, Nishtar Medical University Multan.
Department of Dermatology, Bahawal-Victoria Hospital/Quaid-e-Azam Medical College.
J Nutr Sci Vitaminol (Tokyo). 2021;67(1):68-71. doi: 10.3177/jnsv.67.68.
The aim of the present study was to estimate the prevalence of telogen effluvium (TE) and to evaluate the efficacy of vitamin D in the treatment of this problem in women belonging to various cities of south Punjab, Pakistan. In the present study, 40 adult women suffering from the problem of TE were included. Each woman was treated with oral vitamin D (200,000 IU) therapy fortnightly and a total of 6 doses were given to each patient. After 15 d of the last dose, the condition of patients was assessed clinically. The mean age of female patients was 32.2±1.5 y, 42.5% of the patients between 21-30 y of age were found to be more frequently affected with TE compared to 35% females of 31-40 y of age. Results showed significant improvement in hair growth in young (r=0.457 p<0.003) women and in those, which do not use sunscreen (r=-0.331 p<0.037) but commonly utilize milk or milk protein (r=-0.311 p<0.051). Vitamin D therapy resulted in the improvement of the condition in 82.5% (p<0.001) patients of TE. The use of oral vitamin D (200,000 IU, fortnightly) for 3 mo resulted in significant improvement in hair regrowth in the patient of TE. Results showed improvement in hair growth in young women those do not use sunscreen but commonly utilize milk or milk protein.
本研究旨在评估休止期脱发（TE）的患病率，并评估维生素 D 治疗巴基斯坦旁遮普省南部不同城市女性 TE 问题的疗效。在本研究中，纳入了 40 名患有 TE 问题的成年女性。每位女性均接受口服维生素 D（20 万 IU）治疗，每两周一次，共给予每位患者 6 剂。末次剂量后 15 天，临床评估患者病情。女性患者的平均年龄为 32.2±1.5 岁，21-30 岁的患者中有 42.5%比 31-40 岁的女性患者更常受 TE 影响（35%）。结果显示，年轻女性（r=0.457，p<0.003）和不使用防晒霜的女性（r=-0.331，p<0.037），以及经常使用牛奶或牛奶蛋白的女性（r=-0.311，p<0.051），头发生长明显改善。维生素 D 治疗使 82.5%（p<0.001）的 TE 患者病情得到改善。使用口服维生素 D（20 万 IU，每两周一次）治疗 3 个月可显著改善 TE 患者的毛发生长。结果显示，不使用防晒霜但经常使用牛奶或牛奶蛋白的年轻女性的头发生长有所改善。
